Date of this Version

2022

Keywords

Candida auris, fungal pathogen, antifungal resistance

Abstract

Candida auris is an emerging fungal pathogen that poses a significant public health concern due to the species’ increasing resistance to a vast array of FDA-approved antifungal drugs and high mortality rate. The pathogenic fungus has also proven difficult to identify within a conventional diagnostic laboratory and has been responsible for numerous outbreaks in healthcare settings across the globe, as noted by the Center for Disease Control and Prevention (source). This research effort aims to provide a comprehensive review detailing the history, origin, and biological characteristics of C. auris with particular emphasis on analyzing the nature of C. auris’s multidrug-resistant capabilities against currently FDA-approved and experimental treatment methods alike.

Share

COinS